JMP Securities downgraded shares of Expensify (NASDAQ:EXFY – Free Report) from an outperform rating to a market perform rating in a research report released on Monday morning, Marketbeat Ratings reports.
Expensify Stock Performance
EXFY stock opened at $3.27 on Monday. The company has a market capitalization of $252.31 million, a PE ratio of -18.17 and a beta of 1.51. Expensify has a one year low of $1.24 and a one year high of $3.47. The company’s 50 day moving average price is $2.20 and its two-hundred day moving average price is $1.98.
Insider Activity
In related news, CFO Ryan Schaffer sold 12,500 shares of Expensify stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $2.27, for a total transaction of $28,375.00. Following the sale, the chief financial officer now directly owns 152,531 shares in the company, valued at $346,245.37. The trade was a 7.57 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO David Michael Barrett sold 11,095 shares of the business’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of $2.28, for a total transaction of $25,296.60. Following the sale, the chief executive officer now owns 173,820 shares in the company, valued at approximately $396,309.60. This trade represents a 6.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 185,607 shares of company stock valued at $485,361. Insiders own 17.33% of the company’s stock.
Institutional Investors Weigh In On Expensify
About Expensify
Expensify, Inc provides a cloud-based expense management software platform to individuals and corporations, small and midsized businesses, and enterprises in the United States and internationally. The company’s platform enables users to manage corporate cards, pay bills, generate invoices, collect payments, and book travel.
Featured Articles
- Five stocks we like better than Expensify
- Do ETFs Pay Dividends? What You Need to Know
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Stock Sentiment Analysis: How it Works
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Expensify Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Expensify and related companies with MarketBeat.com's FREE daily email newsletter.